https://lirametostatinhibitor.....com/general-endothel
The nature of ADEs, including type, root cause, and harm, remained consistent across both periods. Despite advancements in patient safety technologies and practices, we observed anticoagulation-associated adverse drug events. The frequency of events was high, suggesting only minimal gains in anticoagulant safety over time, and revealing substantial potential for improvement. Patient safety improvements and technological advancements were in
Like
Comment
Share
